Navigation Links
Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand

Agency will lead public relations efforts to promote OTC cold and flu and allergy products

Los Angeles, CA (PRWEB) January 8, 2008 - Matrixx Initiatives, Inc., has selected GolinHarris as agency of record to lead its public relations initiatives for Zicam® LLC, a wholly owned subsidiary. The agency is charged with ongoing strategic counsel, product messaging, traditional media outreach and developing innovative social media programs. The account will be led out of the Los Angeles office by Negin Kamali, vice president, and Judy Johnson, regional managing director, with new media leadership from Scott Arenson, vice president of social media in the agency's Dialogue digital group. Zicam, one of the fastest growing over-the-counter cold products, is clinically proven to reduce the duration and severity of the common cold.
"We sought out an agency with a strong track record in consumer health products, traditional media relations and social media," said Bill Hemelt, Zicam's acting president. "We're especially excited about the work GolinHarris is doing for us in new media, including launching Zicam's first-ever mobile application for Google's new Android phone and the Apple iPhone, search engine optimization, as well as a number of social media applications."

"The cold and flu season is here and our work with Zicam is already in motion," said Judy Johnson, managing director of GolinHarris' western region. "The Cold and Flu Companion mobile application is just one of several strategies that we're employing to help consumers learn more about Zicam."

About Matrixx Initiatives
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly owned subsidiary, markets and sells Zicam® and Nasal ComfortTM products in the cough and cold category. The company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Swabs(TM); Zicam Cold Remedy ChewablesTM; Zicam Cold Remedy Oral MistTM; Zicam Cold Remedy RapidMeltsTM; Zicam Allergy Relief; Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at For investor information, contact Bill Barba, Treasurer, at 602-385-8881.

About GolinHarris
GolinHarris is a leading public relations agency offering a distinctive combination of global resources and personalized service in the Americas, Asia Pacific, Europe and the Middle East. Clients include Dow Chemical Company, McDonald's Corporation, Nintendo of America Inc., Orange, Texas Instruments and Toyota Motor Sales USA, Inc. GolinHarris celebrated its 50th anniversary in 2006, and is proud to have been selected as 2007 Agency of the Year by The Holmes Report, Large PR Agency of the Year in the PRWeek Awards, PRWeek Magazine's 2007 Editors' Choice and 2008 International Agency of the Year by PRCA. The agency is headquartered in Chicago and is part of the Interpublic Group of Companies (NYSE: IPG). For more information, visit or to join GolinHarris' discussion on the future of public relations, visit

Media Contact: Kathy Maiorana (312) 729-4246


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
2. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2008 Financial Results
3. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
5. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
6. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
7. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
8. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
9. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
10. Health Plans, Employers Take Closer Look at Costs and Expand Disease Management Initiatives in Response to Diabetes Prevalence Increase
11. Newly Reactivated Health Economics Research Institute to Launch New Initiatives for Improving Health Care Delivery
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... to the creativity of two inventors, one from Lakewood, New Jersey and the other ... They developed the patent-pending PROTECTOR to save the expense of having to replace NuvaRings ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
Breaking Medicine Technology: